Key Highlights

  • Cyabra (NASDAQ:CYAB) traded at USD 0.1420, up 7.09%, in pre-market trading on Tuesday, October 27, 2026. No announcement dated Monday, October 26, 2026 or Tuesday, October 27, 2026 was identified; the latest was Wednesday, October 21, 2026.
  • Second quarter 2026 revenue was a record USD 1.9 million, up 39% from USD 1.3 million, with gross margin of about 84% and a net loss of about USD 3.4 million, per the company's release of Thursday, August 13, 2026.
  • October brought a multi-award contract position with the FBI, an enterprise agreement with a Fortune 500 media company and a National Security Advisory Council chaired by Michael R. Pompeo.
  • The share price is far below USD 1.00 and market data show a market value of about USD 3.75 million, so pre-market quotes are thin and volatile.

The Pre-Market Move and Its Catalyst

Cyabra (NASDAQ:CYAB), a company selling artificial intelligence software that detects disinformation, impersonation and influence campaigns, traded at USD 0.1420, up 7.09%, in pre-market trading on Tuesday, October 27, 2026. This is a pre-market snapshot, and prices can change before the open at 9:30 a.m. ET. No company-specific announcement dated Monday, October 26, 2026 or Tuesday, October 27, 2026 accompanied the move. The most recent release, of Wednesday, October 21, 2026, named the company a Sample Vendor, meaning a representative provider, in 10 Gartner Hype Cycle reports. The move appears consistent with continued interest after the October contract announcements and with thin pre-market liquidity. Both readings are inferences, not reported causes.

How the Latest Results Frame the Move

Why the October news matters is visible in the second quarter figures. The company's release of Thursday, August 13, 2026 reported revenue of USD 1.9 million for the quarter ended Tuesday, June 30, 2026, up 39% from USD 1.3 million and up from 12% growth in the first quarter. Gross profit was about USD 1.5 million, a margin of about 84%. Operating expenses comprised research and development of about USD 2.1 million, sales and marketing of about USD 1.3 million and general and administrative costs of about USD 1.3 million. The operating loss was about USD 3.1 million and the net loss was about USD 3.4 million, against USD 2.4 million a year earlier. New customers contributed about USD 0.7 million of revenue. The release also noted a USD 6.0 million private placement and gave no guidance.

Risks and What to Watch

The bull reading rests on 39% revenue growth, an 84% gross margin and the federal pipeline, including the FBI multi-award indefinite delivery, indefinite quantity contract positions, whose five-year ordering period runs through September 2031. The bear reading rests on a quarterly net loss of about USD 3.4 million set against a market value of about USD 3.75 million per market data, which implies repeated financing needs. Named risks include dilution, a share price well below the USD 1.00 level that Nasdaq listing rules use as a minimum bid benchmark, and the fact that contract positions do not guarantee orders. No listing notice was identified in the releases reviewed. Investors should watch the third quarter results for the period ended Wednesday, September 30, 2026, for which no date has been announced, and the Federal Reserve decision on Wednesday, October 28, 2026.

Where Things Stand

The answer is that Cyabra (NASDAQ:CYAB) rose 7.09% pre-market without a dated announcement, and the October contract news and thin liquidity are the more consistent explanations. The key number is USD 1.9 million of second quarter revenue, up 39%, against a net loss of about USD 3.4 million. The next catalysts are the third quarter report, any orders under the FBI contract positions and the Federal Reserve decision on Wednesday, October 28, 2026. Pre-market prices are snapshots and can change, and this is not investment advice.